<?xml version="1.0" encoding="UTF-8"?>
<p>Several studies considered headache and dizziness as the most common neurologic symptom reported by patients affected by SARS-CoV-2.
 <sup>
  <xref rid="r3" ref-type="bibr">3</xref>,
  <xref rid="r4" ref-type="bibr">4</xref>
 </sup> Mao et al.
 <sup>
  <xref rid="r4" ref-type="bibr">4</xref>
 </sup> described a wide array of CNS manifestations, the most common being dizziness (16.8%) followed closely by headache (13.1%). In a large study conducted across China throughout January 2020, which included 1099 patients, headache was reported overall in 13.6% of patients.
 <sup>
  <xref rid="r3" ref-type="bibr">3</xref>
 </sup> A more noteworthy finding was that a greater percentage (15%) of those with more severe illness complained of headache.
 <sup>
  <xref rid="r3" ref-type="bibr">3</xref>
 </sup> Although mostly considered a rather non-specific symptom of any viral infection, headache has been largely present in most studies conducted across the world, ranging from 3% to as high as 13% in some studies.
 <sup>
  <xref rid="r3" ref-type="bibr">3</xref>,
  <xref rid="r4" ref-type="bibr">4</xref>,
  <xref rid="r59" ref-type="bibr">59</xref>–
  <xref rid="r61" ref-type="bibr">61</xref>
 </sup> Nevertheless, headache can often be a forerunner of viral meningitis or encephalitis and is often the premonitory symptom of a cerebrovascular event.
 <sup>
  <xref rid="r60" ref-type="bibr">60</xref>
 </sup>
</p>
